Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 16/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL580314 | 0.86 | CASP1 (0.76) | CASP1SMN1; SMN2ALDH1A1HSD17B10PPARA | |
| SCHEMBL7255594 | 0.84 | CASP1 (0.53) | CASP1SMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL1752817 | 0.83 | CASP1 (1.00) | CASP1KDM4E | |
| SCHEMBL7255661 | 0.82 | CASP1 (0.69) | CASP1ALDH1A1 | |
| SCHEMBL27225888 | 0.75 | CASP1 (0.56) | CASP1SMN1; SMN2ALDH1A1HSD17B10KDM4E | |
| SCHEMBL30850823 | 0.75 | CASP1 (0.56) | CASP1SMN1; SMN2ALDH1A1HSD17B10KDM4E | |
| SCHEMBL7255590 | 0.73 | CASP1 (0.57) | CASP1 | |
| SCHEMBL581917 | 0.73 | CASP1 (0.53) | CASP1SMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL30962961 | 0.73 | CASP1 (0.53) | CASP1SMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL530338 | 0.73 | CASP1 (0.57) | CASP1SMN1; SMN2NPC1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003080616-A1 | PYRAZOLOPYRIDAZINE DERIVATIVES, PROCESS FOR PREPARATION AND USE FOR THE INHIBITION OF GSK-3 | GLAXO GROUP LIMITED (GB) | 2003-10-02 | — | — | WO | disclosed |